glp-1 nmda Informative 🧵 on the new anti-obesity GLP-1—MK-801 conjugate from @OdgaardJonas @BueKlein and @ClemmensenC Lab 👇🏼 glp-1 nmda The G Protein-First

Hidayat K, Zhou Y-Y, Du H-Z, Qin L-Q, Shi B-M, Li Z-N

Efficacy and safety of iGlarLixi, fixed-ratio combination of insulin glargine and lixisenatide, compared with basal-bolus regimen in patients with type 2 diabetes: propensity score matched analysis

For instance, the hormone glucagon-like peptide-1 (GLP-1) stimulates insulin release and inhibits glucagon release (which raises blood glucose)

Why Addressing Weight is Crucial Carrying excess weight can significantly impact your overall health, increasing the risk of conditions such as type 2 diabetes, high blood pressure, and heart disease

A 2022 meta-analysis published in Obesity Reviews found that participants taking GLP-1 receptor agonists typically experienced 25 to 40% of their weight loss from lean masswithin an expected and manageable range when considering dietary interventions or bariatric surgery

And thats exactly the kind of support youll find here